BioRestorative Therapies Executes 1-for-20 Reverse Split to Regain Nasdaq Compliance
BRTX is trading near its 52-week low of $0.159 (7.8% above the low).
Summary
BioRestorative Therapies filed a 1-for-20 reverse stock split effective September 7, 2026, cutting outstanding shares from 27.6M to ~1.38M to regain Nasdaq's $1.00 minimum bid compliance.
Key Events · Corporate Governance and Compliance · BRTX
-
1-for-20 Reverse Split Effective Sept 7
Every 20 shares combine into 1 share at 4:30 p.m. ET on September 7, 2026; trading begins on a split-adjusted basis September 8 under new CUSIP 090655705.
-
Share Count Cut 95%
Outstanding shares drop from 27,622,556 to approximately 1,381,128; authorized shares reduced proportionately from 1.5 billion to 75 million.
-
Nasdaq Compliance Motive
The split is intended to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). At today's $0.1718 price, the post-split equivalent is ~$3.44.
-
Distress Context
Follows a going-concern warning, a Nasdaq delisting notice for the late Q2 10-Q, suspended biocosmeceutical shipments, and a CEO/CFO/board overhaul disclosed September 1.
Analysis · BRTX · Industrial Applications And Services
BioRestorative Therapies is executing a 1-for-20 reverse stock split effective September 7, 2026, reducing outstanding shares from 27.6 million to approximately 1.38 million. The move is explicitly aimed at regaining compliance with Nasdaq's $1.00 minimum bid price requirement. At today's price of $0.1718, the post-split equivalent would be approximately $3.44 per share — comfortably above the threshold, but the company itself warns the increase may not be sustained. This comes amid a cascade of distress: a going-concern warning, a Nasdaq delisting notice for the late Q2 10-Q, suspended product shipments, and a sweeping leadership overhaul just days ago. The reverse split is a survival maneuver, not a fundamental improvement.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRTX was trading at $0.17 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.16 to $1.73. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.